Page 31 - Breakthrough Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vicarious Surgical Appoints Michael Pratt as Vice President of Commercial Strategy Industry veteran to lead commercial growth strategy for Vicarious Surgical technology News provided by Share this article Share this article WALTHAM, Mass., June 3, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced the appointment of Michael Pratt as Vice President of Commercial Strategy. In this new role,...

TORONTO, May 28, 2021 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage…

  ATRIUM HEALTH, WAKE FOREST BAPTIST HEALTH, WAKE FOREST SCHOOL OF MEDICINE  AND RENALYTIX PARTNER TO ADVANCE KIDNEY HEALTH   Partnership marks a long-term commitment to reducing impact of kidney disease in large populations via integration of earlier risk assessment paired with comprehensive disease management   NEW YORK, CHARLOTTE AND WINSTON-SALEM, N.C., May, 19 2021 -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), Atrium Health, Wake Forest Baptist Health and Wake Forest School of Medicine announ...

 surrounding a comprehensive panel of novel biomarkers in kidney disease   NEW YORK, April 14, 2021  - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) announced today that it has entered into an exclusive option agreement with Joslin Diabetes Center for patent filings on certain additional novel biomarkers in kidney disease for development and deployment in the KidneyIntelX in vitro prognostic platform.   These novel biomarkers have the potential to provide additional clinical utility for understanding early disease progression and risk...

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure Clinical findings published in the April issue of Diabetologia, the official journal of the European Association for the Study of Diabetes April 05, 2021 07:00 ET | Source: Renalytix AI plc. Renalytix AI plc. New York, New York, UNITED STATES NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) -- RenalytixAI plc (LSE: RENX) (NASDAQ: RNLX), announced today that KidneyI...